Effects of Cimetidine on Caffeine Disposition in Smokers and Nonsmokers
Overview
Authors
Affiliations
The absorption, distribution, and elimination of caffeine, 2 mg/kg by mouth, were evaluated in six smokers and six nonsmokers before and on the fourth day of administration of cimetidine, 300 mg by mouth every 6 hr. Caffeine absorption, assessed by the maximal serum caffeine concentration (C max) and the time to reach Cmax (t max), was very rapid relative to elimination. The total body clearance (TBC) of caffeine was higher (2.49 +/- 0.35 and 1.59 +/- 0.19 ml/kg/min, P less than 0.05) and the elimination half-life (t1/2) shorter (190 +/- 15 and 276 +/- 30 min, P less than 0.05) in smokers than nonsmokers, but Cmax, tmax, and the apparent volume of distribution (Vd, app) did not differ (P greater than 0.05). Cimetidine decreased the TBC of caffeine by 31% (to 1.73 +/- 0.28 ml/kg/min, P less than 0.05) and by 42% (to 0.92 +/- 0.11 ml/kg/min, P less than 0.01) in smokers and nonsmokers. The increases in t1/2 were 45% (to 276 +/- 25 min, P less than 0.05) and 96% (to 542 +/- 123 min, P less than 0.05). Cmax, tmax, and Vd, app were unaffected by cimetidine. Caffeine induced similar slight increases in blood pressure and pulse rate in smokers and nonsmokers both before and during cimetidine dosing.
Grzegorzewski J, Bartsch F, Koller A, Konig M Front Pharmacol. 2022; 12:752826.
PMID: 35280254 PMC: 8914174. DOI: 10.3389/fphar.2021.752826.
The clinical toxicology of caffeine: A review and case study.
Willson C Toxicol Rep. 2018; 5:1140-1152.
PMID: 30505695 PMC: 6247400. DOI: 10.1016/j.toxrep.2018.11.002.
Quantitative Prediction of Drug Interactions Caused by CYP1A2 Inhibitors and Inducers.
Gabriel L, Tod M, Goutelle S Clin Pharmacokinet. 2016; 55(8):977-90.
PMID: 26936044 DOI: 10.1007/s40262-016-0371-x.
Caffeine Consumption and Heart Rate and Blood Pressure Response to Regadenoson.
Bitar A, Mastouri R, Kreutz R PLoS One. 2015; 10(6):e0130487.
PMID: 26098883 PMC: 4476756. DOI: 10.1371/journal.pone.0130487.
Klotz U, Reimann I Pharm Res. 2013; 1(2):59-62.
PMID: 24277213 DOI: 10.1023/A:1016347229923.